Use of phosphate salts as an adjunct to vitamin D in the treatment of hypophosphatemic vitamin D refractory rickets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of phosphate salts as an adjunct to vitamin D in the treatment of hypophosphatemic vitamin D refractory rickets

Published:1964-04 Issue:4 Volume:64 Page:469-477
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

West Clark D.,Blanton Joseph C.,Silverman Frederic N.,Holland Nancy H.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference11 articles.

1. The diagnosis and management of the various types of rickets;Fraser;Pediat. Clin. North. America,1958

2. Results of calcium infusion and renal biopsy studies in refractory rickets (Abst. 14);Nigrin,1962

3. Familial vitamin D resistant rickets;Harrison,1962

4. Rickets;Harrison,1960

5. Familial hypophosphatemia and vitamin D resistant rickets;Williams,1960

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Burosumab in X-linked Hypophosphatemia;The Journal of Clinical Endocrinology & Metabolism;2023-07-27

2. What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review;Therapeutic Advances in Rare Disease;2022-01

3. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study;Orphanet Journal of Rare Diseases;2020-06-30

4. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial;The Lancet;2019-06

5. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial;The Lancet Diabetes & Endocrinology;2019-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3